In gastric cancer, the interplay between gastric cancer cells and mesenchymal stem cells sustains the growth and properties of gastric CSCs in vivo, activating the R-spondin/Lgr5 axis and the WNT/β-catenin signalling pathway, as indicated by nuclear β-catenin localisation [139]. The gene discussed is LGR5; the disease is gastric cancer.